Pregnant and Postpartum Women Treatment Reauthorization Act
- Bill Number
- S. 1004
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-03-12: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Last Updated
- 2026-06-23T16:25:24Z
AI-Generated Summary
Purpose
This legislation, titled the "Pregnant and Postpartum Women Treatment Reauthorization Act," aims to extend and update a federal program that funds residential treatment services for pregnant and postpartum women dealing with substance use disorders (SUD). The program helps provide specialized care to improve maternal and infant health outcomes by supporting recovery in a residential setting.
Key Provisions
- Program Reauthorization: Renews the existing program under Section 508 of the Public Health Service Act, which grants funds to organizations offering residential treatment for women with SUD during pregnancy and up to one year postpartum.
- Application Requirements: Entities applying for grants must submit a detailed plan outlining how they will deliver services. This plan can include strategies to reach out to women who are disproportionately affected by maternal SUD, such as those in underserved communities.
- Funding Allocation: Authorizes $38,931,000 annually for fiscal years 2025 through 2029 to support the program.
Significant Changes to Existing Law
- Minor Terminology Update: Changes the phrase "providing health services" to "providing health care services" in a section describing eligible grantees, for clarity without altering meaning.
- Enhanced Planning for Outreach: Adds a requirement for grant applicants to describe their service delivery plan and optionally include targeted outreach efforts to address disparities in maternal SUD.
- Increased and Extended Funding: Raises the annual funding amount from about $30 million (for fiscal years 2019–2023) to nearly $39 million and extends authorization through fiscal year 2029, providing more resources and longer-term support.
Potential Impacts
- On Government Agencies: The U.S. Department of Health and Human Services (HHS), which oversees the program, will manage higher funding levels, potentially increasing administrative oversight to ensure equitable distribution and effective use of resources.
- On Citizens: Pregnant and postpartum women with SUD, especially those in high-risk or underserved groups, may gain better access to residential treatment, leading to improved recovery rates, healthier pregnancies, and reduced risks to infants (e.g., from neonatal abstinence syndrome). This could lower long-term healthcare costs related to SUD complications.
- On International Relations: No direct impacts, as the bill focuses on domestic public health programs.
Main Stakeholders Affected
- Pregnant and Postpartum Women with SUD: Primary beneficiaries, gaining expanded access to supportive treatment.
- Healthcare and Treatment Providers: Residential programs and nonprofits that receive grants, which can now plan for targeted outreach and benefit from increased funding.
- Federal and State Governments: HHS for program administration; states and local agencies may see indirect benefits through partnerships in delivering services.
- Families and Communities: Infants and families of affected women, potentially experiencing better health outcomes and reduced social service needs.
Notable Legal, Constitutional, or Political Implications
- Legal: Strengthens the framework of the Public Health Service Act by promoting evidence-based SUD treatment without creating new mandates, ensuring compliance with federal grant rules for accountability.
- Constitutional: Aligns with Congress's authority under the Spending Clause to fund public health initiatives, supporting equal protection by addressing disparities in maternal care without raising equal protection challenges.
- Political: Bipartisan support (introduced by senators from both parties) highlights a consensus on maternal health priorities; the funding increase reflects a policy shift toward greater investment in women's health and SUD prevention, potentially influencing future budgets amid ongoing opioid crisis discussions.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (4)
Sen. Scott, Tim [R-SC], Sen. Klobuchar, Amy [D-MN], Sen. Capito, Shelley Moore [R-WV], Sen. Tillis, Thomas [R-NC]
Recent Actions
- 2025-03-12: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2025-03-12: Introduced in Senate
Bill Versions
- Pregnant and Postpartum Women Treatment Reauthorization Act — issued 2025-03-12 — PDF (2 pages)